The European Mobile Laboratory, EMLab, was the first EBOV diagnostics unit deployed to the outbreak epicentre by WHO in March 2014.
Travel Medicine and Infectious Diseases have evolved rapidly in recent decades as outbreaks such as SARS, Avian Influenza, Ebola, MERS, Chikungunya, and Zika virus have demonstrated how quickly infections can cross international borders.
Great article from our colleagues at the African Society for Laboratory Medicine about Zika virus.
Video seminar by Chelsea McMullen, Operational Support Officer, International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), presented at the University of Oxford, 21st October 2015
Call for Papers: Special issue on strengthening tuberculosis diagnostic networks in Africa - African Journal of Laboratory Medicine
Ebola: the race to find a cure
by Sarah BoseleyCould scientists make history and change the way we deal with outbreaks?
Damalie Nakanjako (MBChB, MMED, PhD) is an internist whose work focuses on optimizing HIV treatment outcomes and reducing HIV-associated morbidity and mortality in sub-Saharan Africa.
Video of Professor Peter Horby, the University of Oxford, on how he and his team set up clinical trials in the heart of the Ebola outbreak.
East African Leaders Join Together to Develop Country-Specific Plans for Point-of-Care Testing.
Two great articles from the African Society for Laboratory Medicine looking at the increasing risk posed by antimicrobial resistance.
Professor Lang talks about doing difficult trials in difficult places - including malaria and ebola trials.
The Federation of Infectious Diseases Societies of Southern Africa (FIDSSA) Quarterly Journal
by Karla LamUsing parasite population genetics to understand transmission dynamics in NTDs
by The Editorial TeamSchistosomiasis, is a chronic, debilitating disease. Uganda began a National Control Programme in 2003 with annual MDA of praziquantel. MDA on this scale provides strong selective pressures on the parasite population with an associated risk of drug resistance developing.
Development of Leishmania vaccines in the era of visceral leishmaniasis elimination
by Christian R. Engwerdaa and Greg MatlashewskibChronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope
by Alexander J. Stockdale and Anna Maria GerettiReducing Deaths from Malaria
by Dr Richard MaudeIntestinal intraepithelial lymphocyte activation promotes innate antiviral resistance
by Mahima Swamy et alIn this seminar from January 2014, Dr Jane Crawley talks about clinical standardisation in PERCH (Pneumonia Etiology Research for Child Health), a large case-control study of the causes of and risk factors for severe pneumonia.
In this lecture Professor Adrian Hill talks about the latest advances in the development of vaccines for Malaria and Ebola.
Infectious diseases and Microbiology videos
by Nuffield Department of MedicineDr Nat Segaren - Medical Director of the Caris Foundation, presents on 'The Haiti National Early Infant Diagnosis of HIV Program'
Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain
by Vegard Eldholm et alIn this seminar Professor Kevin Marsh describes how knowledge of immunity to malaria in humans has developed over the past thirty years and what impact this has for future research.
Ebola Virus Entry: A Curious and Complex Series of Events
by Sven Moller-Tank, Wendy MauryABRAID – The Atlas of Baseline Risk Assessment for Infectious Diseases - Call for feedback
by Dr Catherine MoyesABRAID, new website of infectious diseases risk maps
The Ebola Outbreak - Possible Implications that Media Reporting may Have -
by Cecaro M and Ramsamy YPioneering New Diagnostics: Addressing Challenges and Implications for Point-of-Care Testing in African Settings
by Laurel OldachNeutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
by Philipp Kruger et alA Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections
by Kfir Oved, et alUNICEF Cholera Toolkit
by UNICEFHIV/AIDS diagnostics technology landscape
by UnitaidHepatitis C diagnostics technology landscape
by UnitaidEarly Virus-Host Interactions Dictate the Course of a Persistent Infection
by Brian M. Sullivan, John R. Teijaro, Juan Carlos de la Torre, Michael B. A. OldstoneRapid and Inexpensive Detection of MDR Mycobacterium tuberculosis using a Resazurin Microtitreplate Assay in a High Burden Tuberculosis Reference Laboratory
by Prenika Jaglal, Melendhran Pillay, Koleka MlisanaProfessor Peter Piot, LSHTM, talks about Ebola and implications for Africa and understanding future epidemics at the Martin School, University of Oxford, 16th October 2014.
Ebola PPE guidelines - urgent need to revise WHO and CDC guidelines. This video shows an excerpt from keynote address 'The fuss about face masks', Professor Raina MacIntyre from the School of Public Health and Community Medicine, UNSW Australia.
The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis.
by Emily P. Hyle et al.Aging and HIV/AIDS: pathogenetic role of therapeutic side effects
by Rebecca A Torres and William LewisThe Ebola virus epidemic may well spread out of Africa. Dr Greg Martin takes a look at some of the variables that contribute to this risk and discusses some steps that should be taken.
An Integrated Lab-on-Chip for Rapid Identification and Simultaneous Differentiation of Tropical Pathogens
by Jeslin J. L. Tan, Monica Capozzoli, et alEvaluation of a Typhoid/Paratyphoid Diagnostic Assay (TPTest) Detecting Anti-Salmonella IgA in Secretions of Peripheral Blood in Lymphocytes in Patients in Dhaka, Bangladesh
by Farhana Khanam, Alaullah Sheikh, Abu Sayeed, Saraur Bhuiyan, Feroza Kaneez Choudhury, Umme Salma, Shahnaz Pervin, Tania Sultana, Dilruba Ahmed, Doli Goswami, Lokman Hossain, KZ Mamun, Richell C Charles, W. Abdullah Brooks, Stephen B. Calderwood, Alejandro Cravioto, Edward T Ryan, Firdausi QadriProspective Evaluation of Three Rapid Diagnostic Tests for Diagnosis of Human Leptospirosis
by Marga GA Goris, Mariska MG Leeflang, Martin Loden, Jiri FP Wagenaar, Paul Klatser, Rudy A Hartseerl, Kimberly R BoerClinical Research Laboratories for Trials in Global Health in Central Africa
by ALI Innocent, akindeh, Prof Wilfred F. MbachamThe authors present the story of building a succesful research laboratory in Cameroon, including how they managed building up the infrastructure, equipment maintenance, staff training.